SLC9A1 and endothelial dysfunction: Zhu and colleagues found that SeQDs can inhibit the activity of Na+/H+ exchanger 1 (NHE1) and impair calcium ion/calpain signaling, effectively improving endothelial cell relaxation, preventing endothelial dysfunction, and limiting the growth of atherosclerotic plaques (Zhu et al., 2019).